Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The ZNF217 Biomarker Predicts Low- and High-Risk Oncotype DX® Recurrence Score in ER-Positive Invasive Breast Cancers

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • بيانات النشر:
      Frontiers Media S.A., 2019.
    • الموضوع:
      2019
    • Collection:
      LCC:Therapeutics. Pharmacology
    • نبذة مختصرة :
      We assessed mRNA and protein expression levels of the ZN217 oncogene in 17 clinical FFPE ER-positive invasive breast cancer specimens with known (low or high) Oncotype DX® Recurrence Scores. This study shows that mRNA or nuclear protein levels of the ZNF217 significantly correlate with Oncotype DX® Recurrence Score.
    • File Description:
      electronic resource
    • ISSN:
      1663-9812
    • Relation:
      https://www.frontiersin.org/article/10.3389/fphar.2019.00524/full; https://doaj.org/toc/1663-9812
    • الرقم المعرف:
      10.3389/fphar.2019.00524
    • الرقم المعرف:
      edsdoj.7278250e47264b61bccb337945c470a9